UCL BUSINESS PLC

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 74181
 
 
 
C07K PEPTIDES 4393
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 33134
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 26180
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 14226
 
 
 
A61F FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, E.G. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS 11129
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 11114
 
 
 
A61L METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES 1061
 
 
 
G06K RECOGNITION OF DATA; PRESENTATION OF DATA; RECORD CARRIERS; HANDLING RECORD CARRIERS 8190
 
 
 
C07D HETEROCYCLIC COMPOUNDS 7155

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0028,117 ULTRASOUND PROBEJan 08, 16Feb 01, 18[G10K, A61B]
2018/0028,570 Angiogenic FactorsJul 27, 17Feb 01, 18[A61K, C12P, C07K, A61L]
2017/0334,998 CHIMERIC ANTIGEN RECEPTOR (CAR) WITH ANTIGEN BINDING DOMAINS TO THE T CELL RECEPTOR BETA CONSTANT REGIONMay 26, 17Nov 23, 17[A61K, G01N, C07K]
2017/0300,372 METHOD AND APPARATUS FOR THE DETECTION OF FAULTS IN DATA COMPUTATIONSSep 02, 15Oct 19, 17[G06F]
2017/0291,875 QUINOLONES AS INHIBITORS OF CLASS IV BROMODOMAIN PROTEINSAug 28, 15Oct 12, 17[A61K, C07D, G01N]
2017/0267,726 NON-IMMUNOSUPPRESSIVE CYCLOSPORIN DERIVATIVES AS ANTIVIRAL AGENTSMay 30, 17Sep 21, 17[C07K]
2017/0240,920 METHOD AND MEANS FOR PURIFYING RETROVIRAL VECTORSAug 28, 15Aug 24, 17[C12N, C07K]
2017/0189,364 COMPOSITIONS COMPRISING ORNITHINE AND PHENYLACETATE OR PHENYLBUTYRATE FOR TREATING HEPATIC ENCEPHALOPATHYFeb 10, 17Jul 06, 17[A61K]
2017/0184,570 DIAGNOSTICSJul 08, 15Jun 29, 17[C12Q, G01N]
2017/0157,112 HIF INHIBITORSNov 25, 14Jun 08, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
D813386 SpeculumApr 17, 17Mar 20, 18[2402]
9907798 Methods of treating head and neck cancerJul 01, 16Mar 06, 18[A61K, C12Q, G01N, A61N, C07K]
9896729 Method for diagnosing a neurodegenerative diseaseAug 31, 12Feb 20, 18[C07H, A61K, C12Q, G01N]
9897619 Analyte extraction apparatus and methodFeb 17, 14Feb 20, 18[C12Q, G01N]
9861276 Supra-threshold test and a sub-pixel strategy for use in measurements across the field of visionMay 05, 11Jan 09, 18[A61B]
9844568 Porous carbon particles for use in the treatment or prevention of liver diseaseMar 15, 13Dec 19, 17[A61K]
9840720 Materials and methods relating to packaging cell linesFeb 13, 13Dec 12, 17[A61K, C12N]
9837091 Audio-visual dialogue system and methodAug 19, 14Dec 05, 17[G06T, G10L]
9801955 Methods and compositions for detecting drusen and predicting age-related macular degenerationAug 30, 13Oct 31, 17[A61K, G01N]
9804256 Apparatus and method for determining the location of a mobile device using multiple wireless access pointsOct 18, 13Oct 31, 17[G01S, H04W]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2016/0333,073 DRUG DELIVERY SYSTEMAbandonedJan 21, 15Nov 17, 16[A61K, G01N, C07K]
2016/0187,761 IMAGING APPARATUS AND METHODSAbandonedJul 10, 15Jun 30, 16[G02B, G02F]
2016/0175,308 THERAPEUTIC AGENTS FOR MODULATING THYMIC FUNCTION AND/OR GROWTH AND/OR TREATING VARIOUS DISORDERSAbandonedMay 02, 14Jun 23, 16[A61K]
2016/0166,658 THERAPEUTIC INTERVENTIONAbandonedJul 17, 14Jun 16, 16[A61K, A61N]
2016/0145,329 Composition for Intraocular Implantation of BevacizumabAbandonedNov 16, 15May 26, 16[A61K, C07K]
2016/0145,615 AGONISTS OF DDAH1 FOR TREATING ENDOTHELIAL DYSFUNCTIONAbandonedJun 17, 14May 26, 16[A61K, C12Q, C12N]
2016/0120,938 P2X7 RECEPTOR AGONIST FOR USE IN PREVENTING OR TREATING KIDNEY INJURYAbandonedApr 23, 14May 05, 16[A61K, G01N]
2016/0115,466 ENZYME AND USES THEREOFAbandonedMay 16, 14Apr 28, 16[A61K, C12N, C07K]
2016/0002,299 NON-IMMUNOSUPPRESSIVE CYCLOSPORIN DERIVATIVES AS ANTIVIRAL AGENTSAbandonedMar 03, 14Jan 07, 16[C07K]
2015/0311,072 METHOD OF PREPARING A SUBSTRATE FOR NANOWIRE GROWTH, AND A METHOD OF FABRICATING AN ARRAY OF SEMICONDUCTOR NANOSTRUCTURESAbandonedApr 21, 15Oct 29, 15[H01L]
2015/0240,369 Electrolysis ElectrocatalystAbandonedSep 20, 13Aug 27, 15[C25B]
2015/0190,391 INHIBITORS OF NKX2.5 FOR VASCULAR REMODELLINGAbandonedJul 18, 13Jul 09, 15[A61K, C12N]
2015/0160,176 Apparatus and Method for Testing MedicamentsAbandonedMay 02, 13Jun 11, 15[G01N]
2015/0057,160 PATHOGEN SCREENINGAbandonedJul 20, 12Feb 26, 15[C12Q]
2015/0037,350 NEGATIVE MODULATOR OF HEDGEHOG SIGNALLING FOR USE IN TREATING TH2-MEDIATED DISEASESAbandonedMar 15, 13Feb 05, 15[A61K, C07K]
2015/0031,861 Chemical Modification of AntibodiesAbandonedMar 08, 13Jan 29, 15[A61K, C07K]
2015/0017,185 METHOD TO IMPROVE THE IMMUNE FUNCTION OF T CELLSAbandonedNov 29, 12Jan 15, 15[A61K, C12N, C07K]
2015/0010,910 BIOMARKERS FOR AGE-RELATED MACULAR DEGENERATION (AMD)AbandonedFeb 21, 13Jan 08, 15[C12Q]
2014/0363,405 METHOD FOR OBTAINING MAB-LIKE CELLS AND USES THEREOFAbandonedJan 18, 13Dec 11, 14[A61K]
2014/0357,569 CYCLOSPORIN CONJUGATESAbandonedFeb 28, 14Dec 04, 14[C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.